ArticleLiver cancer2023

Drug-Off Criteria in Patients with Hepatocellular Carcinoma Who Achieved Clinical Complete Response after Combination Immunotherapy Combined with Locoregional Therapy.

Masatoshi KudoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.